What MICROMUN GmbH does

MICROMUN Institut für Mikrobiologische Forschung GmbH is a privately held specialised laboratory founded in 1993 in Greifswald, Mecklenburg-West Pomerania, Germany, by virologist Prof. Dr. Leopold Döhner. The company provides microbiological, molecular biological, virological, immunochemical, and biochemical testing and research services to B2B clients, primarily pharmaceutical manufacturers, food and beverage companies, water utilities, disinfectant manufacturers, and diagnostic laboratories. It operates nine core service lines — drug testing, disinfectant testing, diagnostic antigen production, antiviral substance screening, virus and TSE clearance studies, molecular biological contamination diagnostics, microbiological water testing, food testing, and collaborative R&D projects — under GLP certification (since 1997), GMP certification (since 2003), and DIN EN ISO/IEC 17025 accreditation for food and drinking water testing (since 2022).

The company's technical infrastructure centres on high-safety laboratories — over 500 m² comprising one S3 safety laboratory, four S2 laboratories, and a cell culture laboratory — located in the Biotechnikum complex in Greifswald, a city with historical significance in virology due to the work of Friedrich Loeffler. MICROMUN deploys PCR/qPCR/RT-qPCR for molecular diagnostics, MALDI-TOF mass spectrometry for rapid pathogen identification in food samples, and LAL endotoxin testing according to the European Pharmacopoeia; Nanopore sequencing is in development. The company also operates the BioÖkonomieZentrum, a 13,000 m² innovation centre near Anklam housing 18 tenants, generating additional recurring rental income.

MICROMUN's go-to-market is direct B2B project-based contracting with quote-based pricing, supplemented by diagnostic antigen sales and BioÖkonomieZentrum facility rentals. It serves clients nationally and internationally, with cross-border R&D collaborations including a 2025 Interreg (Germany-Poland) project. The company is led by Prof. Dr. Beatrice Großjohann as CEO (Geschäftsführerin), with 7 total employees, no disclosed external investors, no funding rounds, and no disclosed revenue figure.

Name

MICROMUN GmbH

Legal name

MICROMUN Institut für Mikrobiologische Forschung GmbH

Website

https://micromun.de

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Microbiological and Virological Laboratory Testing Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511)

SIC

Services-Testing Laboratories (8734), In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility) (HLAGADAE)

akta.pro secondary industries

Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF), Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD), Microbiological Water Testing (Coliform/E. coli, HPC, Legionella) (AFALAJAD)

Keywords

• Microbiological testing services
• Virological safety testing
• Virus clearance studies
• Pharmaceutical laboratory testing
• Food and water microbiology

Headquarters

HQ city

Murchin

HQ country

Germany

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Contract Laboratory Testing Services: MICROMUN provides commissioned laboratory testing services for pharmaceutical manufacturers, food companies, and other industrial clients. Services include drug testing, disinfectant testing, virus clearance studies, molecular biological diagnostics, water testing, and food testing under GLP, GMP, and ISO 17025 certifications. Revenue is generated through project-based contracts and individual testing commissions.
2. Diagnostic Antigens Sales: Sale of in-house manufactured diagnostic antigens to customers for use in immunological assays.
3. Facility Rental (BioÖkonomieZentrum): Rental of office, laboratory, production, storage, and conference spaces at the BioÖkonomieZentrum innovation centre to tenants, generating recurring rental income.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

MICROMUN GmbH is a specialized contract laboratory that performs GLP- and GMP-compliant microbiological, molecular biological, virological, and immunochemical testing and research services for pharmaceutical manufacturers, food producers, water utilities, and disinfectant makers. Its offering spans drug testing, virus and TSE clearance studies, molecular diagnostics of contaminants (PCR/qPCR/Nanopore sequencing), microbiological food and water testing (including LAL endotoxin testing and MALDI-TOF-MS pathogen identification), antiviral disinfectant and substance testing, and in-house production of diagnostic antigens. The company also operates the BioÖkonomieZentrum innovation centre near Anklam, renting office, laboratory, and event space to tenants.

Product overview

MICROMUN GmbH is a specialized private laboratory offering comprehensive services in virology, microbiology, and molecular biology. The company operates nine core service offerings: Arzneimittelprüfungen (drug testing under GMP conditions), Desinfektionsmittelprüfungen (disinfectant antiviral efficacy testing), Diagnostische Antigene (diagnostic antigen production including rotavirus and adenovirus antigens), Screening antiviraler Substanzen (antiviral substance screening and assay development), Virusabreicherungsstudien (virus and TSE clearance studies under GLP), Molekularbiologische Diagnostik von Kontaminationen (molecular biological diagnostics using PCR and Nanopore sequencing), Mikrobiologische Untersuchung von Wasser (microbiological water testing for drinking, pool, and pharmaceutical water), Lebensmittelüberprüfung (ISO 17025-accredited food testing with MALDI-TOF-MS), and F&E Projekte (collaborative R&D projects). The company also operates the BioÖkonomieZentrum innovation center in Anklam.

Differentiator

Problem solved

Functional benefit

Products and services

• Arzneimittelprüfungen (Drug Testing) Develops test methods and investigates drugs on behalf of pharmaceutical manufacturers under GMP conditions using cell biological, molecular biological, immuno-chemical and biochemical methods; determines virus load for a broad spectrum of animal- and human-pathogenic viruses in drugs of biological origin.
• Desinfektionsmittelprüfungen (Disinfectant Testing) Provides expert opinions on the antiviral action of disinfectants for manufacturers and suppliers according to European guidelines (DIN EN 14476), Robert-Koch-Institute guidelines, and German VAH/DGHM, DVV, and DVG standards.
• Diagnostische Antigene (Diagnostic Antigens) Produces and supplies diagnostic antigens manufactured in-house from pathogenic microorganisms and cell cultures, including specific viral and microbiological antigens such as rotavirus and adenovirus antigens, for use in immunological assays.
• Screening antiviraler Substanzen (Antiviral Substance Screening) Tests substances for their antiviral and cytotoxic potency on customer commission and develops corresponding assays tailored to the customer's research and development needs.
• Virusabreicherungsstudien (Virus Clearance Studies) Conducts virus and TSE clearance studies under GLP conditions to validate the safety of pharmaceutical manufacturing processes against viral and prion contamination.
• Molekularbiologische Diagnostik von Kontaminationen (Molecular Biological Diagnostics) Validated methods for qualitative and quantitative detection of viruses and microorganisms using conventional PCR, real-time qPCR, RT-real-time qPCR, and Nanopore sequencing — capable of detecting zoonotic and human pathogenic DNA and RNA viruses, phages, bacteria, yeasts, moulds, and GMOs.
• Mikrobiologische Untersuchung von Wasser (Microbiological Water Testing) Microbiological water analysis for drinking water, swimming pool water, and pharmaceutical industry water — including total colony count, intestinal enterococci, E. coli, coliform bacteria, Pseudomonas aeruginosa, Legionella spp., and LAL testing for bacterial endotoxins.
• Lebensmittelüberprüfung (Food Testing) ISO 17025-accredited bacteriological testing of finished food products, semi-finished products, animal feed, and raw materials, using MALDI-TOF-MS for rapid identification of potentially pathogenic microorganisms, including salmonella screening.
• F&E Projekte (R&D Projects) Participation in collaborative research and development projects such as pig bile to ursodeoxycholic acid, industrial hemp as cover crop, apple pomace for fungal protein production, pharmaceutical-quality bioethanol from sugar beets, sundew as antifungal agent, and flax-based food products.
• BioÖkonomieZentrum Facility Rental Rental of office, laboratory, production, storage, outdoor, conference room, and academy (up to 100 seats) space at the BioÖkonomieZentrum innovation centre in Anklam — directly to bioeconomy tenants and event customers; currently more than 18 tenants on site.

Quantifiable outcome

• Over 220 vocational pupils and 100 university students trained through internships since founding
• +1 more outcomes

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

16 partnerships are on record, tiered minor and core.

• Universität GreifswaldminorStrategic or Co-development Partner · 1 August 2025Academic partner in the Flaxinuum cross-border project developing innovative food products from flaxseed press cake. Contributes pharmaceutical and life science expertise.
• Pomersche Medizinische Universität Stettin (Pomeranian Medical University in Szczecin)minorStrategic or Co-development Partner · 1 August 2025Academic partner in the Flaxinuum cross-border Interreg project (Germany-Poland), contributing medical university expertise in investigating antimicrobial, anti-inflammatory, and anticancer effects of flax-based products.
• BCC Energie GmbHminorStrategic or Co-development Partner · 1 July 2024Energy partner in the KEEN Greifswald (Communal Energy Efficiency Network) project, working on heat supply in communal heating networks, seawater as a heat source, and utilisation of green waste heat and biomethane.
• Universität Greifswald, Abteilung Pharmazeutische BiologieminorStrategic or Co-development Partner · 1 April 2024Academic partner in the sundew (Sonnentau) antifungal project, contributing pharmaceutical biology expertise for developing plant-based pharmaceuticals against Candida infections.
• Universität Greifswald, Abteilung Biopharmazie und Pharmazeutische TechnologieminorStrategic or Co-development Partner · 1 April 2024Academic partner in the sundew antifungal project, contributing biopharmacy and pharmaceutical technology expertise.
• Paludimed GmbHminorStrategic or Co-development Partner · 1 April 2024External partner in the sundew (Sonnentau) project contributing expertise in paludiculture (cultivation of wetland plants).
• Cosun Beet Company GmbH & Co. KGminorStrategic or Co-development Partner · 1 January 2024Project partner for developing pharmaceutical-quality bioethanol from organic sugar beet pulp. CBC produces bioethanol from sugar beet processing residues and aims to meet European Pharmacopoeia standards.
• Universität Rostock, Abteilung Technische und Analytische ChemieminorStrategic or Co-development Partner · 1 January 2024Academic partner in the pharmaceutical-quality bioethanol project, contributing technical and analytical chemistry expertise.
• Lassaner Fruchtsäfte Mosterei Nowack GbRminorStrategic or Co-development Partner · 1 January 2023Project partner in the APPLE project (Apfelbasiertes PiLzmyzEl), which aims to develop apple pomace as a high-quality protein source through fungal biotechnology. MICROMUN contributes its expertise in product safety testing.
• Zentrum für Ernährung und Lebensmitteltechnologie (ZELT) gGmbHminorStrategic or Co-development Partner · 1 January 2023Project partner in the APPLE project for processing apple pomace into protein sources. ZELT contributes expertise in food technology and nutrition.
• Forschungsinstitut für Nutztierbiologie (FBN)minorStrategic or Co-development Partner · 16 June 2022Research partner in the ZwiHanf project investigating industrial hemp as a catch crop to reduce nitrate and greenhouse gas emissions. FBN contributes animal science research expertise.
• HANF FARM Landwirtschaft UG & Co. KGminorStrategic or Co-development Partner · 16 June 2022Agricultural partner in the ZwiHanf project for cultivating industrial hemp as a winter catch crop.
• Food and Pharma Services Anklam GmbHminorStrategic or Co-development Partner · 16 June 2022Partner in the ZwiHanf project contributing food and pharmaceutical services expertise.
• Hochschule Neubrandenburg, Fachbereich Agrarwirtschaft und LebensmittelwissenschaftenminorStrategic or Co-development Partner · 16 June 2022Academic partner in the ZwiHanf project contributing agricultural economics and food science expertise.
• BioResQ gGmbHcoreStrategic or Co-development Partner · 1 January 2019BioResQ gGmbH is the sister company of MICROMUN and the most important on-site partner at the BioÖkonomieZentrum. BioResQ acts as an initiator for sustainable and future-oriented bioeconomy, operating in consulting (sustainability reporting, biobased business strategies and regulatory affairs), education and public relations (school projects, workshops), R&D, and networking.
• Hygiene Nord GmbHcoreStrategic or Co-development PartnerMICROMUN cooperates with Hygiene Nord GmbH for disinfectant testing services. While MICROMUN provides expert opinion on antiviral activity of disinfectants, Hygiene Nord GmbH specialises in testing the antibacterial and fungicidal action of disinfectants, complementing each other's capabilities.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Sartorius AG: German-headquartered bioprocessing and laboratory product company serving pharmaceutical and biotechnology manufacturers with quality testing and validation services; comparable end customers and German life-sciences ecosystem as MICROMUN.
• bioMérieux SA: Global leader in industrial and clinical microbiology diagnostics, supplying instruments, reagents and testing services including pathogen identification and endotoxin testing — broader incumbent with overlapping technologies (e.g. MALDI-TOF, LAL) used by MICROMUN.
• IDEXX Laboratories: Global leader in water microbiology testing (Legionella, coliforms, HPC) and food safety diagnostics — directly comparable to MICROMUN's microbiological water testing and food pathogen identification service lines, particularly with MALDI-TOF-based workflows.

Direct peers

• GBA Laboratory Group: German contract laboratory group providing food, water, pharmaceutical and environmental testing services including microbiology — a direct sub-scale peer competing with MICROMUN in the same German B2B segments.
• Eurofins Scientific: Global market leader in food, environmental, pharmaceutical and clinical testing with extensive microbiology and sterility service lines that directly overlap MICROMUN's pharma, food and water testing portfolio; competes on scale and price across the same B2B customers.
• SGS Société Générale de Surveillance: Global testing, inspection and certification company with life sciences, food and environmental microbiology services; competes with MICROMUN for international pharma and food manufacturer testing contracts.
• SYNLAB AG: Europe's largest medical diagnostics services provider operating medical and analytical laboratories across multiple countries; directly comparable to MICROMUN's clinical/medical microbiology testing and ambulatory lab offerings, particularly in Germany and the EU.
• WuXi AppTec: Global CRO/CDMO offering biologics safety testing, virus clearance and bioanalytical services to pharma manufacturers — competes for the same outsourcing contracts MICROMUN serves in virology and endotoxin testing.
• Charles River Laboratories: Global CRO offering Biologics Safety Testing including virus clearance studies, cell banking and endotoxin testing for pharma manufacturers — closely mirrors MICROMUN's GMP/GLP virology and endotoxin service lines.

Emerging players

• Labor LS SE & Co. KG: Mid-sized German contract laboratory focused on pharmaceutical, food and cosmetics testing with microbiological capabilities; a closer-size peer serving similar German SME customers as MICROMUN.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/micromun-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MICROMUN GmbH